Perspectives of In-Hospital Intramuscular Naltrexone and Oral Medications for Alcohol Use Disorder: A Study of
Susan L Calcaterra1,2, Sarah Mann3, Eric Grimm3
1Division of Hospital Medicine, Department of Medicine, University of Colorado, Aurora, CO, USA. Susan.calcaterra@cuanschutz.edu.
Background:
Alcohol-related hospitalizations are rising; however, medications for alcohol use disorder (M-AUD) are underprescribed despite their effectiveness to reduce heavy drinking. In-hospital administration of intramuscular (IM)-naltrexone may reduce negative health outcomes among people with AUD who are unable to take daily MAUD.
Objective:
To assess addiction clinicians' perceptions of offering and administering IM-naltrexone and to assess hospitalized patients' perspectives on their alcohol use and acceptance of MAUD.
Design:
Multi-methods using surveys and semi-structured interviews.
Setting And Participants:
Hospital-based addiction clinicians (n = 20) and hospitalized patients with AUD (n = 25) at a university hospital.
Approach:
Descriptive statistics were used for quantitative data analysis. Key informants were identified using convenience sampling; inductive and deductive methods were used to analyze interview transcripts.
Key Results:
Clinicians reported that offering and administering in-hospital IM-naltrexone was acceptable, appropriate, and feasible before and after it became available to hospitalized patients. Most patients (92%) accepted IM-naltrexone before agreeing to an interview. Themes emerged related to patient's complicated relationship with alcohol, ranging from minimizing alcohol's impact on their family and health, to concerns about how alcohol was negatively affecting them and their loved ones. Many acknowledged that alcohol damaged their health, while also describing ambivalence about their alcohol use or being incapable of reducing their alcohol use. Others expressed motivation and assuredness of sobriety with IM-naltrexone. Most reported accepting IM-naltrexone because they hoped it would improve their health and relationships, because it was convenient, and because it offered security over a pill. Others used alcohol to self-manage challenging emotions and had difficulty considering a life without it.
Conclusions:
ACS clinicians viewed IM-naltrexone provision favorably. Some patients expressed concern about their alcohol use and its health impacts while others were ambivalent. Despite this, most accepted MAUD. All forms of MAUD should be offered in the hospital to support patients' recovery goals.
More Related Videos
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
05:40The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans
Published on: April 28, 2022
Related Concept Videos
01:27CNS Depressants: Alcohol and Nicotine
01:17Drug Dependence
01:15Drug Abuse and Addiction: Pharmacological Phenomena
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
01:30Specialized Care Centers and Settings-II
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
01:28Drug Therapy
Antianxiety Medications